Behavioral insensitivity to restraint stress, absent fear suppression of behavior and impaired spatial learning in transgenic rats with hippocampal neuropeptide Y overexpression
Open accessThe DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Abstract
Exogenous neuropeptide Y (NPY) reduces experimental anxiety in a wide range of animal models. The generation of an NPY-transgenic rat has provided a unique model to examine the role of endogenous NPY in control of stress and anxiety-related behaviors using paradigms previously used by pharmacological studies. Locomotor activity and baseline behavior on the elevated plus maze were normal in transgenic subjects. Two robust phenotypic traits were observed. ( i ) Transgenic subjects showed a markedly attenuated sensitivity to behavioral consequences of stress, in that they were insensitive to the normal anxiogenic-like effect of restraint stress on the elevated plus maze and displayed absent fear suppression of behavior in a punished drinking test. ( ii ) A selective impairment of spatial memory acquisition was found in the Morris water maze. Control experiments suggest these traits to be independent. These phenotypic traits were accompanied by an overexpression of prepro-NPY mRNA and NPY peptide and decreased NPY-Y1 binding within the hippocampus, a brain structure implicated both in memory processing and stress responses. Data obtained using this unique model support and extend a previously postulated anti-stress action of NPY and provide novel evidence for a role of NPY in learning and memory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat
Pellow, S., Chopin, P., File, S. E., & Briley, M. (1985) · Journal of Neuroscience Methods · doi:10.1016/0165-0270(85)90031-7 · Cited by 5,822
Spatial localization does not require the presence of local cues
Morris, R. G. M. (1981) · Learning and Motivation · doi:10.1016/0023-9690(81)90020-5 · Cited by 2,699
Tatemoto, K., Carlquist, M., & Mutt, V. (1982) · Nature · doi:10.1038/296659a0 · Cited by 2,269
Pellow, S., & File, S. E. (1986) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(86)90552-6 · Cited by 1,532
(2000) · Cited by 919
Modulation of Anxiety and Neuropeptide Y-Y1 Receptors by Antisense Oligodeoxynucleotides
Wahlestedt, C., Pich, E. M., Koob, G. F., Yee, F., & Heilig, M. (1993) · Science · doi:10.1126/science.8380941 · Cited by 527
Self-citationEthanol consumption and resistance are inversely related to neuropeptide Y levels
Thiele, T. E., Marsh, D. J., Ste. Marie, L., Bernstein, I. L., & Palmiter, R. D. (1998) · Nature · doi:10.1038/24614 · Cited by 468
Cloned human neuropeptide Y receptor couples to two different second messenger systems.
Herzog, H., Hort, Y. J., Ball, H. J., Hayes, G., Shine, J., & Selbie, L. A. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.13.5794 · Cited by 434
Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type.
Larhammar, D., Blomqvist, A. G., Yee, F., Jazin, E., Yoo, H., & Wahlested, C. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49854-2 · Cited by 422
Cited by
Charney, D. S. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.2.195 · Cited by 1,605
Smoking, stress, and negative affect: Correlation, causation, and context across stages of smoking.
Kassel, J. D., Stroud, L. R., & Paronis, C. A. (2003) · Psychological Bulletin · doi:10.1037/0033-2909.129.2.270 · Cited by 1,080
The neurobiology and control of anxious states
Millan, M. J. (2003) · Progress in Neurobiology · doi:10.1016/s0301-0082(03)00087-x · Cited by 965
Neuroendocrine pharmacology of stress
Carrasco, G. A., & Van de Kar, L. D. (2003) · European Journal of Pharmacology · doi:10.1016/s0014-2999(03)01285-8 · Cited by 914
The NPY system in stress, anxiety and depression
Heilig, M. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.002 · Cited by 614
Self-citationMillan, M. J. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.11.006 · Cited by 551
Neuropeptide, Y, peptide YY and pancreatic polypeptide in the gut-brain axis
Holzer, P., Reichmann, F., & Farzi, A. (2012) · Neuropeptides · doi:10.1016/j.npep.2012.08.005 · Cited by 501
“NPY overexpression attenuates anxiety-like responses induced by restraint stress (Thorsell et al., 2000) much as repeated infusion”
Neuropeptide Y: a stressful review
Reichmann, F., & Holzer, P. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.008 · Cited by 490
Developmental Control of Foraging and Social Behavior by the Drosophila Neuropeptide Y-like System
Wu, Q., Wen, T., Lee, G., Park, J. H., Cai, H. N., & Shen, P. (2003) · Neuron · doi:10.1016/s0896-6273(03)00396-9 · Cited by 436
Cortical GABAergic Dysfunction in Stress and Depression: New Insights for Therapeutic Interventions
Fogaça, M. V., & Duman, R. S. (2019) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2019.00087 · Cited by 396
Goodman, A. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2007.07.030 · Cited by 413
Neuropeptide systems as novel therapeutic targets for depression and anxiety disorders
Holmes, A., Heilig, M., Rupniak, N. M. J., Steckler, T., & Griebel, G. (2003) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2003.09.011 · Cited by 403
Self-citationThe neurocircuitry and receptor subtypes mediating anxiolytic-like effects of neuropeptide Y
Kask, A., Harro, J., von Hörsten, S., Redrobe, J. P., Dumont, Y., & Quirion, R. (2002) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(01)00066-5 · Cited by 358
Self-citationRole of neuropeptides in anxiety, stress, and depression: From animals to humans
Kormos, V., & Gaszner, B. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.014 · Cited by 329
Rimondini, R., Arlinde, C., Sommer, W., & Heilig, M. (2002) · The FASEB Journal · doi:10.1096/fj.01-0593com · Cited by 321
Self-citationCohen, H., Liu, T., Kozlovsky, N., Kaplan, Z., Zohar, J., & Mathé, A. A. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.230 · Cited by 299
Self-citationNPY and Y receptors: lessons from transgenic and knockout models
Lin, S., Boey, D., & Herzog, H. (2004) · Neuropeptides · doi:10.1016/j.npep.2004.05.005 · Cited by 282
Regulation of aversion to noxious food by Drosophila neuropeptide Y– and insulin-like systems
Wu, Q., Zhao, Z., & Shen, P. (2005) · Nature Neuroscience · doi:10.1038/nn1540 · Cited by 278
Berglund, M. M., Hipskind, P. A., & Gehlert, D. R. (2003) · Experimental Biology and Medicine · doi:10.1177/153537020322800301 · Cited by 260
Yehuda, R., Brand, S., & Yang, R.-K. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.027 · Cited by 243
The role of NPY in hypothalamic mediated food intake
Mercer, R. E., Chee, M. J. S., & Colmers, W. F. (2011) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2011.06.001 · Cited by 198
Reduced anxiety and improved stress coping ability in mice lacking NPY‐Y2 receptors
Tschenett, A., Singewald, N., Carli, M., Balducci, C., Salchner, P., Vezzani, A., Herzog, H., & Sperk, G. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02725.x · Cited by 180
“In addition, a crucial role of endogenous NPY in anxiety was demonstrated by the anxiogenic effect induced by intra-amygdaloid injection of a Y1 receptor antisense probe (Wahlestedt et al., 1993) and reduced anxiety observed in NPY over-expressing rats (Thorsell et al., 2000).”
BackgroundHeilig, M., Zachrisson, O., Thorsell, A., Ehnvall, A., Mottagui-Tabar, S., Sjögren, M., Åsberg, M., Ekman, R., Wahlestedt, C., & Ågren, H. (2004) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(03)00101-8 · Cited by 177
Self-citationNeuropeptide Y and posttraumatic stress disorder
Sah, R., & Geracioti, T. D. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.101 · Cited by 166
The role of NPY in learning and memory
Gøtzsche, C. R., & Woldbye, D. P. D. (2016) · Neuropeptides · doi:10.1016/j.npep.2015.09.010 · Cited by 165
“retention of spatial memories, presumably mediated via presynaptic Y2 receptor-mediated inhibition of glutamatergic transmission (Thorsell et al., 2000).”
InfluentialBowers, M. E., Choi, D. C., & Ressler, K. J. (2012) · Physiology & Behavior · doi:10.1016/j.physbeh.2012.03.004 · Cited by 155
“It was found that acute restraint stress reduced anxiogenic responses on the elevated plus maze for WT but not transgenic rats overexpressingNPY [114].”
The homeostatic role of neuropeptide Yin immune function and its impact on mood and behaviour
Farzi, A., Reichmann, F., & Holzer, P. (2015) · Acta Physiologica · doi:10.1111/apha.12445 · Cited by 145
“Indeed, hippocampal NPY overexpression protects from the anxiety-producing effects of stress (Thorsell et al. 2000), and repeated administration of NPY into the basolateral amygdala generates resilient mice that are protected from the negative consequences of stress (Sajdyk et al. 2008).”
BackgroundResultMaul, S., Giegling, I., Fabbri, C., Corponi, F., Serretti, A., & Rujescu, D. (2020) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32763 · Cited by 125
“In several brain regions (hippocampus, hypo- thalamus, LC, and amygdala) corticotropin-releasing hormone mediated anxiogenic effects are counteracted by NPY, which is neces- sary for the compensation of stress reaction and homeostasis (Thorsell et al., 2000).”
BackgroundEffect of Y1 receptor deficiency on motor activity, exploration, and anxiety
Karl, T., Burne, T. H. J., & Herzog, H. (2006) · Behavioural Brain Research · doi:10.1016/j.bbr.2005.08.019 · Cited by 95
Thorsell, A., Repunte-Canonigo, V., O'Dell, L. E., Chen, S. A., King, A. R., Lekic, D., Koob, G. F., & Paolo Sanna, P. (2007) · Brain · doi:10.1093/brain/awm033 · Cited by 91
“Correspondence to: George F. Koob, Committee on the Neurobiology of Addictive Disorders, The Scripps Research Institute, 10550 NorthTorrey Pines Road SP30-2400, La Jolla, CA 92037, USA E-mail: gkoob@scripps.edu Acute administration of neuropeptideY (NPY) modulates alcohol intake in genetic and…”
BackgroundMethodSelf-citationBeck, B., & Pourié, G. (2013) · Nutrition Reviews · doi:10.1111/nure.12045 · Cited by 86
A randomized dose-ranging study of neuropeptide Y in patients with posttraumatic stress disorder
Sayed, S., Van Dam, N. T., Horn, S. R., Kautz, M. M., Parides, M., Costi, S., Collins, K. A., Iacoviello, B., Iosifescu, D. V., Mathé, A. A., et al. (2018) · International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyx109 · Cited by 79
Self-citationReduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice
Painsipp, E., Wultsch, T., Edelsbrunner, M. E., Tasan, R. O., Singewald, N., Herzog, H., & Holzer, P. (2008) · Genes, Brain and Behavior · doi:10.1111/j.1601-183x.2008.00389.x · Cited by 79
“The cognitive deficits associated with Y2 receptor knockout are consistent with the region-specific effects of intracerebral NPY injections and the amnesia resulting from NPY overexpression in the hippocampus (Flood et al. 1989; Redrobe et al. 2004a; Thorsell et al. 2000).”
BackgroundNeuropeptides and hippocampal neurogenesis
Zaben, M. J., & Gray, W. P. (2013) · Neuropeptides · doi:10.1016/j.npep.2013.10.002 · Cited by 75
CCK and NPY as anti-anxiety treatment targets: promises, pitfalls, and strategies
Harro, J. (2006) · Amino Acids · doi:10.1007/s00726-006-0334-x · Cited by 64
Witt, S. H., Buchmann, A. F., Blomeyer, D., Nieratschker, V., Treutlein, J., Esser, G., Schmidt, M. H., Bidlingmaier, M., Wiedemann, K., Rietschel, M., et al. (2011) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2010.12.015 · Cited by 54
Neuropeptide Y: History and Overview
Tatemoto, K. (2004) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-642-18764-3_1 · Cited by 52
“sumption and some of the intoxicating effects caused by administration of etha nol ( Thiele et al. 2002 ).”
BackgroundSweis, B. M., Veverka, K. K., Dhillon, E. S., Urban, J. H., & Lucas, L. R. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.04.052 · Cited by 39
“A number of behavioral, pharmacological, and genetic studies have demonstrated how NPY exerts anxiolytic effects on behavior, particularly recruited during chronic stress as an adaptive affective coping mechanism (Thorsell et al., 1999, 2000).”
BackgroundLyons, A. M., & Thiele, T. E. (2010) · Peptides · doi:10.1016/j.peptides.2010.09.009 · Cited by 21
“In fact, accumulating evidence indicates that NPY signaling in the BLA and hippocampus protect against anxiety-like behaviors in rodents [17,23,27,29], reinforcing the idea that an upregulation of NPY signaling in these regions accounts for the reduced anxietylike behavior in mice given BMH infusion of NPY-SAP.”
Background
Metadata
- Authors
- Thorsell, A., Michalkiewicz, M., Dumont, Y., Quirion, R., Caberlotto, L., Rimondini, R., Mathé, A. A., & Heilig, M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 2000-10-31
- Volume
- 97
- Issue
- 23
- Pages
- 12852-12857
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2048625352
- Cited by
- 315
- References
- 45
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.